Roxana Schillaci

Company: Institute of Biology and Experimental Medicine CONICET, Argentina
Job title: Principal Researcher
Seminars:
Resistance to Immunotherapy Caused by MUC4 Expression in HER2+ Tumors – Bench to Bedside 12:00 pm
• Exploring how MUC4 expression predicts resistance to immunotherapy • Targeting soluble TNF reverses resistance in animal models • Understand how knowing the MUC4 status of a patient’s tumor will improve clinical decision making and should benefit patient outcomeRead more
day: Day Two